Effectiveness of venetoclax and azacytidine against myeloid/natural killer cell precursor acute leukemia-Reference-Cited by-同舟云学术

Effectiveness of venetoclax and azacytidine against myeloid/natural killer cell precursor acute leukemia

Published:2023-11-27 Issue:1 Volume:119 Page:88-92
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Shiomi Ichiro,Nakako Soichiro,Nakane Takahiko^ORCID,Ogawa Yumi,Araki Taku,Fujitani Yotaro,Yamamura Ryosuke,Hino Masayuki,Nakamae Hirohisa

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-023-03678-9.pdf

Reference20 articles.

1. Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 1997;90(6):2417–28.

2. Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol. 2007;139(4):532–44.

3. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2017.

4. Suzuki R, Murata M, Kami M, Ohtake S, Asou N, Kodera Y, et al. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0. Int J Hematol. 2003;77(5):482–9.

5. Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res. 1999;23(7):615–24.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastics;Reactions Weekly;2024-04-27